Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Reunion Neuroscience Inc T.REUN

Healthcare Biotechnology
Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a... see more

Bullboard (TSX:REUN)

View:
1 2 3 4 5 Next
Post by Dow20000on Jun 29, 2023 3:44pm

Financials

As of March 31.the company had $ 27 Million in cash which works out to about $ 2.45 a share. Assuming they spend $ 5 Million since,this offer of $ 1.51 is way too low,so I don't understand ...more  
140
Post by Dow20000on Jun 01, 2023 5:25pm

Cash

Does anybody know how much cash is left in the companies treasury?Back in Jan.of this year they were showing $ 32 Million.
138
Comment by ark88on Jun 01, 2023 3:36pm

RE:Cash offer.

Especially considering the deal stipulates the company must have $8mil minimum cash at closing. So they're pricing the company at $5.1 mil which equates to $0.43 per share offer. 
111
Discussion
Post by Dow20000on Jun 01, 2023 1:14pm

Cash offer.

$ 1.12 ? Is this some kind of a joke?
190
Discussion
Post by Betteryear2on Aug 10, 2022 5:23pm

Microdose Announces The 2nd Annual Microdose Awards

Miami, Florida--(Newsfile Corp. - August 9, 2022) - Microdose Psychedelic Insights, the leading guide to the business of psychedelics, is excited to announce the lineup of categories for the 2nd ...more  
399
Post by TrevorAbeson Apr 29, 2022 1:03pm

Field Trip Health to spin off into two public companies

https://themarketherald.ca/field-trip-health-ltd-announces-intention-to-separate-the-field-trip-discovery-and-field-trip-health-divisions-into-two-independent-public-companies-2-2022-04-29/
616
Post by AwareInvestoron Apr 29, 2022 8:02am

Field Trip Health To Divide Into Two Separate Firms

Field Trip Health is set to be split into two separate firms. The company last night indicated that its board has approved an arrangement whereby the firms current operations will split into two ...more  
686
Post by Betteryear2on Apr 28, 2022 6:24pm

Field Trip Health Ltd. Announces Intention

Transaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next generation psychedelic therapies. Shareholders ...more  
606
Post by Betteryear2on Feb 15, 2022 5:22pm

Conference Call

The Company will conduct a conference call and webcast to discuss its results on Wednesday, February 16, 2022 at 8:30am ET. To access the call, please dial 1-877-407-9716 (within the U.S.) or 1-201 ...more  
709
Post by Betteryear2on Feb 15, 2022 5:17pm

Third Fiscal Quarter 2022 Financial Results

Earned patient services revenues of $1,360,811, an increase of 50% over the prior quarter and 330% year over year. At December 31, 2021, Field Trip had approximately $74.5 million in unrestricted ...more  
628
Post by BryceCanadaon Jan 11, 2022 10:31am

Excellent YT analysis on FTRP

https://youtu.be/47XFv8AkGNs
578
Post by BryceCanadaon Jan 10, 2022 10:03pm

Thoughts on AWKN vs FTRP?

https://youtu.be/RI20piHkvEc
537
Comment by evilballson Nov 29, 2021 1:19pm

RE:1 million in sales ,400 million market cap , ah ok

Facebookl was a massive success on ery little revenue for years.  All you have to do is look at the studies. Read the facts. Hear the testimonials. Pyschelics are groundbreaking therapy for many ...more  
684
Discussion
Post by Betteryear2on Oct 19, 2021 8:00am

Continue Expansion With Psychedelic-Assisted Therapy Centers

TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies ...more  
592
1 2 3 4 5 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities